These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 12865319)
41. Two differentially expressed interleukin-11 receptor genes in the mouse genome. Bilinski P; Hall MA; Neuhaus H; Gissel C; Heath JK; Gossler A Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):359-63. PubMed ID: 8973540 [TBL] [Abstract][Full Text] [Related]
42. Defective production of interleukin-11 by decidua and chorionic villi in human anembryonic pregnancy. Chen HF; Lin CY; Chao KH; Wu MY; Yang YS; Ho HN J Clin Endocrinol Metab; 2002 May; 87(5):2320-8. PubMed ID: 11994383 [TBL] [Abstract][Full Text] [Related]
43. Acquiring signalling specificity from the cytokine receptor gp130. Ernst M; Jenkins BJ Trends Genet; 2004 Jan; 20(1):23-32. PubMed ID: 14698616 [TBL] [Abstract][Full Text] [Related]
44. Interleukin-11 signaling is required for the differentiation of natural killer cells at the maternal-fetal interface. Ain R; Trinh ML; Soares MJ Dev Dyn; 2004 Dec; 231(4):700-8. PubMed ID: 15499555 [TBL] [Abstract][Full Text] [Related]
45. Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction. Hilton DJ; Hilton AA; Raicevic A; Rakar S; Harrison-Smith M; Gough NM; Begley CG; Metcalf D; Nicola NA; Willson TA EMBO J; 1994 Oct; 13(20):4765-75. PubMed ID: 7957045 [TBL] [Abstract][Full Text] [Related]
46. Negative regulation of gp130 signalling mediated through tyrosine-757 is not dependent on the recruitment of SHP2. Fairlie WD; De Souza D; Nicola NA; Baca M Biochem J; 2003 Jun; 372(Pt 2):495-502. PubMed ID: 12593670 [TBL] [Abstract][Full Text] [Related]
47. Soluble mannose 6-phosphate/insulin-like growth factor II (IGF-II) receptor inhibits interleukin-6-type cytokine-dependent proliferation by neutralization of IGF-II. Duplomb L; Chaigne-Delalande B; Vusio P; Raher S; Jacques Y; Godard A; Blanchard F Endocrinology; 2003 Dec; 144(12):5381-9. PubMed ID: 12959977 [TBL] [Abstract][Full Text] [Related]
48. Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3. Auernhammer CJ; Isele NB; Kopp FB; Spoettl G; Cengic N; Weber MM; Senaldi G; Engelhardt D Endocrinology; 2003 Apr; 144(4):1202-10. PubMed ID: 12639901 [TBL] [Abstract][Full Text] [Related]
49. Dynamics of the gp130 cytokine complex: a model for assembly on the cellular membrane. Schroers A; Hecht O; Kallen KJ; Pachta M; Rose-John S; Grötzinger J Protein Sci; 2005 Mar; 14(3):783-90. PubMed ID: 15722452 [TBL] [Abstract][Full Text] [Related]
50. A fusion protein of the gp130 and interleukin-6Ralpha ligand-binding domains acts as a potent interleukin-6 inhibitor. Ancey C; Küster A; Haan S; Herrmann A; Heinrich PC; Müller-Newen G J Biol Chem; 2003 May; 278(19):16968-72. PubMed ID: 12646580 [TBL] [Abstract][Full Text] [Related]
51. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. Pflanz S; Hibbert L; Mattson J; Rosales R; Vaisberg E; Bazan JF; Phillips JH; McClanahan TK; de Waal Malefyt R; Kastelein RA J Immunol; 2004 Feb; 172(4):2225-31. PubMed ID: 14764690 [TBL] [Abstract][Full Text] [Related]
52. The length of the interleukin-11 receptor stalk determines its capacity for classic signaling. Lokau J; Garbers C J Biol Chem; 2018 Apr; 293(17):6398-6409. PubMed ID: 29523682 [TBL] [Abstract][Full Text] [Related]
53. The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis. Jenkins BJ; Roberts AW; Najdovska M; Grail D; Ernst M Blood; 2005 May; 105(9):3512-20. PubMed ID: 15650055 [TBL] [Abstract][Full Text] [Related]
54. Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling. Paonessa G; Graziani R; De Serio A; Savino R; Ciapponi L; Lahm A; Salvati AL; Toniatti C; Ciliberto G EMBO J; 1995 May; 14(9):1942-51. PubMed ID: 7744001 [TBL] [Abstract][Full Text] [Related]
55. Impairment of antigen-specific antibody production in transgenic mice expressing a dominant-negative form of gp130. Kumanogoh A; Marukawa S; Kumanogoh T; Hirota H; Yoshida K; Lee IS; Yasui T; Yoshida K; Taga T; Kishimoto T Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2478-82. PubMed ID: 9122220 [TBL] [Abstract][Full Text] [Related]
56. Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6/gp130-mediated cell signaling and proliferation. Moodley YP; Scaffidi AK; Misso NL; Keerthisingam C; McAnulty RJ; Laurent GJ; Mutsaers SE; Thompson PJ; Knight DA Am J Pathol; 2003 Jul; 163(1):345-54. PubMed ID: 12819039 [TBL] [Abstract][Full Text] [Related]
57. Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis. Jenkins BJ; Roberts AW; Greenhill CJ; Najdovska M; Lundgren-May T; Robb L; Grail D; Ernst M Blood; 2007 Mar; 109(6):2380-8. PubMed ID: 17082315 [TBL] [Abstract][Full Text] [Related]
58. Lack of expression of Gp-130 makes pancreatic beta cell lines unresponsive to the IL-6 family of cytokines. Naselli G; Deaizpurua HJ; Thomas HE; Johnston AM; Kay TW Int J Exp Diabetes Res; 2001; 1(4):239-48. PubMed ID: 11467415 [TBL] [Abstract][Full Text] [Related]
59. A designer hyper interleukin 11 (H11) is a biologically active cytokine. Dams-Kozlowska H; Gryska K; Kwiatkowska-Borowczyk E; Izycki D; Rose-John S; Mackiewicz A BMC Biotechnol; 2012 Mar; 12():8. PubMed ID: 22433466 [TBL] [Abstract][Full Text] [Related]